Biogen Plans First Study For Earlier Use Of MS Drug Tysabri
By Thomas Gryta Of DOW JONES NEWSWIRES NEW YORK (Dow Jones) Biogen Idec Inc. (BIIB) is planning the first clinical…
FDA warns of brain risks with frequent Tysabri use
Yahoo Finance FDA finds connection between brain inflammation and frequent use of Tysabri On Friday February 5, 2010, 12:53 pm…
Stuart Schlossman
Benefits of Tysabri far outweigh risks, European watchdog group says about Multiple Sclerosis drug
Tysabri is given by infusion NMMS January 26, 9:43 PMMultiple Sclerosis ExaminerMike Szymanski A drug watchdog group in Europe has…
Stuart Schlossman
Multiple Sclerosis : Tysabri PML Updates Set to Start Again
Date Published: Monday, January 25th, 2010 The maker of Tysabri will once again provide monthly updates regarding new cases of…
Stuart Schlossman
Multiple Sclerosis Related: European regulators recommend Tysabri label update
* European regulators announce PML cases with Tysabri * Say risk of the brain infection remain low * Recommend updating…
Stuart Schlossman
Biogen’s Tysabri Sales Surpass $1 Billion In 2009; Users Rise 30%
NASDAQ.com DOW JONES NEWSWIRES Biogen Idec Inc. (BIIB) said sales of its controversial multiple sclerosis treatment Tysabri surpassed $1 billion in 2009,…
Stuart Schlossman
Biogen to reinstate monthly PML updates
By Geoff Percival Friday, January 08, 2010 BIOGEN IDEC – the Boston-based pharmaceutical firm which co-owns the Tysabri multiple sclerosis…
Stuart Schlossman
Biogen discloses more PML cases
Wednesday, January 6, 2010 – Boston Business Journal – by Julie M. Donnelly Biogen Idec says that four more cases…
Stuart Schlossman
First Infusion Update (Day 2+) by Stuart
In follow-up to what you read yesterday, by 3 in the afternoon, I began losing grogginess and easily by 5pm…
Stuart Schlossman
Stuart’s First Tysabri Infusion – My MS Blog Posting
Of course there is concern (for me) of The PML, but of even greater concern is the loss of being…
Stuart Schlossman
